Bigbear Pharmaceutical·Medication Guide

• How to Use Selumetinib (Koselugo)

  How to Use Selumetinib (Koselugo)Selumetinib (Koselugo) is a kinase inhibitor specifically used to treat symptomatic, unresectable plexiform neurofibr···【Read More】

  Update: 2026-03-18Source: Haiou HealthViews: 121

• Indications for Enasidenib

  Enasidenib is the first FDA-approved treatment for acute myeloid leukemia (AML) targeting IDH2 mutations, indicated for relapsed or refractory adult p···【Read More】

  Update: 2026-03-18Source: Haiou HealthViews: 120

• Ponatinib Precautions and Drug Interactions

  Ponatinib Precautions and Drug InteractionsPonatinib is a third-generation BCR-ABL tyrosine kinase inhibitor developed and manufactured by Takeda Phar···【Read More】

  Update: 2026-03-18Source: Haiou HealthViews: 116

• Ponatinib's Efficacy and Actions

  Ponatinib's Efficacy and ActionsPonatinib is a tyrosine kinase inhibitor that inhibits tumor cell proliferation by targeting and inhibiting the ac···【Read More】

  Update: 2026-03-18Source: Haiou HealthViews: 119

• Efficacy and Actions of Elacestrant

  Efficacy and Actions of ElacestrantElacestrant is an anti-tumor drug, belonging to the estrogen receptor antagonist class.Efficacy and Actions of Elac···【Read More】

  Update: 2026-03-18Source: Haiou HealthViews: 110

• Precautions for Axitinib Use

  Precautions for Axitinib UseAxitinib is an oral, highly selective tyrosine kinase inhibitor developed by Pfizer, primarily used to treat advanced rena···【Read More】

  Update: 2026-03-18Source: Haiou HealthViews: 107

• Dificid's Efficacy and Actions

  Dificid's Efficacy and ActionsDificid was developed by Astellas Pharma in Japan and approved by the US FDA on May 27, 2011.Dificid is a fermentati···【Read More】

  Update: 2026-03-18Source: Haiou HealthViews: 103

• Precautions for Selumetinib Use

  Precautions for Selumetinib UseSelumetinib was approved by the U.S. Food and Drug Administration (FDA) on April 10, 2020, under the brand name Koselug···【Read More】

  Update: 2026-03-18Source: Haiou HealthViews: 115

• Selumetinib's Efficacy and Functions

  Selumetinib's Efficacy and FunctionsDeveloped by AstraZeneca in the UK, selumetinib was officially approved for marketing in China in May 2023 and···【Read More】

  Update: 2026-03-18Source: Haiou HealthViews: 108

• Purchase Channels for Axitinib

  Axitinib is a targeted therapeutic agent for renal cell carcinoma, which has been increasingly widely used in clinical practice in recent years. Devel···【Read More】

  Update: 2026-03-18Source: Haiou HealthViews: 123

• ​Precautions for Enxidipine

  Precautions for EnxidipineEnxidipine is used for relapsed or refractory acute myeloid leukemia (AML) with an IDH2 mutation. An FDA-approved diagnostic···【Read More】

  Update: 2026-03-18Source: Haiou HealthViews: 116

• Precautions for Apellixis Use

  Apellixis is a targeted therapy for a specific type of breast cancer, developed by Novartis in Switzerland and approved by the US FDA in 2019.Precauti···【Read More】

  Update: 2026-03-18Source: Haiou HealthViews: 102

• What to Do in Case of Overdose with Avatrombopag Ethanolamine Tablets

  The maximum recommended daily dose of this drug is 75 mg. Taking more than 75 mg per day, or exceeding the daily dose recommended by a physician based···【Read More】

  Update: 2026-03-18Source: Haiou HealthViews: 116

• What to Do If a Dose of Avatrombopag Ethanolamine Tablets Is Missed

  If one dose is missed during treatment, continue with the original drug dosage and administration schedule.Do not take a double dose at one time to av···【Read More】

  Update: 2026-03-18Source: Haiou HealthViews: 116

• How Long Does the Efficacy of Avatrombopag Ethanolamine Tablets Typically Last

  The elimination half-life of this product is 21–32 hours, meaning it takes 21–32 hours for the plasma drug concentration or total body drug level to d···【Read More】

  Update: 2026-03-18Source: Haiou HealthViews: 116